What is it about?
Biologically based complementary medicines (BB-CMs) are popular in patients with cancer. However, there are only limited data for BB-CMs in patients with neuroendocrine tumors (NET). We aimed to identify the prevalence and type of BB-CM use and the association to the nutritional risk score (NRS-2002) in NET patients We performed a cross-sectional questionnaire study in NET outpatients at the Department of Hepatology and Gastroenterology at Aarhus University Hospital. The nutritional risk was determined by the NRS-2002.
Featured Image
Why is it important?
We showed that 42% used at least two supplements with the most popular being vitamin and mineral supplements (47%), calcium and vitamin D (34%). One-third used non-vitamin non-mineral supplements such as fish oil, herbs, Ginger, Q-10, garlic and probiotics. The use of BB-CMs was associated with female gender in addition to patients reporting dietary changes
Perspectives
In our study, 66% percent of NET patients use BB-CM and 42% used two or more supplements. For clinicians this is important as some of the BB-CM may be associated with drug interactions.
Clinical Chair Professor Henning Gronbaek
Aarhus Universitet
Read the Original
This page is a summary of: Use of biologically based complementary medicines in patients with neuroendocrine tumors, Scandinavian Journal of Gastroenterology, August 2019, Taylor & Francis,
DOI: 10.1080/00365521.2019.1646799.
You can read the full text:
Contributors
The following have contributed to this page
